LLSC webcast series


The LLSC webcast series is an interactive, educational showcase of the progress we have made in understanding, treating and managing blood cancers.

When LLSC was founded in 1955, a diagnosis of leukemia, lymphoma, Hodgkin's disease or myeloma was almost always fatal. Today, thanks to innovative research funded in part by LLSC, survival rates for some blood cancers have doubled and even quadrupled.

Learn more by participating over the telephone and online in upcoming webcasts.

Visit this page to access virtual lectures, audio replays and program slides from past programs.


Immunotherapy: is using the immune system to tackle cancer a reality?

The newest form of cancer treatment is based on the concept that immune cells or antibodies that can recognize and kill cancer cells in the laboratory can then be given to patients to treat cancer. Several types of immunotherapy are either approved for use or are under study in clinical trials to determine their effectiveness in treating various types of cancer, including blood cancers.

Register Me

The topics covered include:

  • Overview of immunotherapy
  • How immunotherapy works
  • Which patients are eligible for immunotherapy
  • Getting the latest treatments to patients


Dr. Denis Claude Roy

Dr. Denis Claude Roy
Professor of Medicine, Université de Montréal
Director of Research, CIUSSS Est-Ile-de-Montréal
CEO, CellCAN Regenerative Medicine and Cell Therapy Network
Scientific Director, Center of Excellence in Cell Therapy


English webcast: February 16, from 2:30 p.m. to 3:45 p.m. ET

The educational webcast is available in French or English, will be approximately 1 hour in length followed by question period and advance registration is required.

Register Me

The French webcast is on February 9, from 2:30 p.m. to 3:45 p.m. ET, and to register, click here.



This Webcast is made possible thanks to the support of


Previous Webcasts:

To watch Lymphoma Research: Yesterday, Today and Tomorrow and all past webcasts, click here.